
Results
2
2 companies
MedinCell
Market Cap: €910.7m
A clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France.
MEDCL
€24.92
7D
-5.3%
1Y
56.6%
DBV Technologies
Market Cap: €719.1m
A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
DBV
€2.43
7D
2.0%
1Y
41.0%